High serum IGFBP-2 is predictive of increased bone turnover in aging men and women

Journal of Bone and Mineral Research

Volumn 22, Issue 6, 2007, Pages 799-807

  Amin, Shreyasee ^a,b   Riggs, B Lawrence ^a   Melton III, L Joseph ^a   Achenbach, Sara J ^a   Atkinson, Elizabeth J ^a   Khosla, Sundeep ^a  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

BMD; Bone formation; Bone resorption; Bone turnover markers; Insulin like growth factor binding protein 2; Insulin like growth factors

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; CARBOXY TERMINAL TELOPEPTIDE; ESTRADIOL; OSTEOCALCIN; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TESTOSTERONE; ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS LINKED PEPTIDE; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; IGFBP1 PROTEIN, HUMAN; IGFBP3 PROTEIN, HUMAN; PEPTIDE; PEPTIDE FRAGMENT; PROCOLLAGEN; PROCOLLAGEN TYPE I CARBOXY TERMINAL PEPTIDE; SOMATOMEDIN BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; AGING; ARTICLE; BODY MASS; BONE TURNOVER; FEMALE; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; OSSIFICATION; OSTEOLYSIS; PREDICTION; STATISTICAL ANALYSIS; URINALYSIS; BLOOD; BONE; BONE DEVELOPMENT; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHYSIOLOGY; PREDICTION AND FORECASTING; SEX DIFFERENCE; URINE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE AND BONES; BONE RESORPTION; COLLAGEN TYPE I; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OSTEOCALCIN; OSTEOGENESIS; PEPTIDE FRAGMENTS; PEPTIDES; PREDICTIVE VALUE OF TESTS; PROCOLLAGEN; SEX FACTORS;

EID: 34548247265     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.070306     Document Type: Article

References (43)

1. Rogol AD 1992 Growth and growth hormone secretion at puberty: The role of gonadal steroid hormones. Acta Paediatr Suppl 383:15-20.
2. Rajaram S, Baylink DJ, Mohan S 1997 Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions. Endocr Rev 18:801-831.
3. Van Wyk JJ, Smith EP 1999 Insulin-like growth factors and skeletal growth: Possibilities for therapeutic interventions. J Clin Endocrinol Metab 84:4349-4354.
4. Bennett AE, Wahner HW, Riggs BL, Hintz RL 1984 Insulin-like growth factors I and II: Aging and bone density in women. J Clin Endocrinol Metab 59:701-704.
5. Kveiborg M, Flyvbjerg A, Rattan SI, Kassem M 2000 Changes in the insulin-like growth factor-system may contribute to in vitro age-related impaired osteoblast functions. Exp Gerontol 35:1061-1074.
6. Amin S, Riggs BL, Atkinson EJ, Oberg AL, Melton LJ III, Khosla S 2004 A potentially deleterious role of IGFBP-2 on bone density in aging men and women. J Bone Miner Res 19:1075-1083.
7. Kim JG, Shin CS, Choi YM, Moon SY, Kim SY, Lee JY 1999 The relationship among circulating insulin-like growth factor components, biochemical markers of bone turnover and bone mineral density in postmenopausal women under the age of 60. Clin Endocrinol (Oxf) 51:301-307.
8. Nasu M, Sugimoto T, Chihara M, Hiraumi M, Kurimoto F, Chihara K 1997 Effect of natural menopause on serum levels of IGF-I and IGF-binding proteins: Relationship with bone mineral density and lipid metabolism in perimenopausal women. Eur J Endocrinol 136:608-616.
9. Johansson AG, Eriksen EF, Lindh E, Langdahl B, Blum WF, Lindahl A, Ljunggren O, Ljunghall S 1997 Reduced serum levels of the growth hormone-dependent insulin-like growth factor binding protein and a negative bone balance at the level of individual remodeling units in idiopathic osteoporosis in men. J Clin Endocrinol Metab 82:2795-2798.
10. van den Beld AW, Blum WF, Pols HA, Grobbee DE, Lamberts SW 2003 Serum insulin-like growth factor binding protein-2 levels as an indicator of functional ability in elderly men. Eur J Endocrinol 148:627-634.
11. Gillberg P, Olofsson H, Mallmin H, Blum WF, Ljunghall S, Nilsson AG 2002 Bone mineral density in femoral neck is positively correlated to circulating insulin-like growth factor (IGF)-I and IGF-binding protein (IGFBP)-3 in Swedish men. Calcif Tissue Int 70:22-29.
12. Sugimoto T, Nishiyama K, Kuribayashi F, Chihara K 1997 Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures. J Bone Miner Res 12:1272-1279.
13. Kim JG, Lee JY 1996 Serum insulin-like growth factor binding protein profiles in postmenopausal women: Their correlation with bone mineral density. Am J Obstet Gynecol 174:1511-1517.
14. Meier C, Nguyen TV, Center JR, Seibel MJ, Eisman JA 2005 High IGFBP-2 levels are associated with an increased risk of osteoporotic fractures in elderly men. J Bone Miner Res 20:S1;S36.
15. Fisher MC, Meyer C, Garber G, Dealy CN 2005 Role of IGFBP2, IGF-I and IGF-II in regulating long bone growth. Bone 37:741-750.
16. Kream BE, Tetradis S, Lafrancis D, Fall PM, Feyen JH, Raisz LG 1997 Modulation of the effects of glucocorticoids on collagen synthesis in fetal rat calvariae by insulin-like growth factor binding protein-2. J Bone Miner Res 12:889-895.
17. Raisz LG, Fall PM, Gabbitas BY, McCarthy TL, Kream BE, Canalis E 1993 Effects of prostaglandin E2 on bone formation in cultured fetal rat calvariae: Role of insulin-like growth factor-I. Endocrinology 133:1504-1510.
18. Firth SM, Baxter RC 2002 Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824-854.
19. Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 16:3-34.
20. Hettmer S, Dannecker L, Foell J, Elmlinger MW, Dannecker GE 2005 Effects of insulin-like growth factors and insulin-like growth factor binding protein-2 on the in vitro proliferation of peripheral blood mononuclear cells. Hum Immunol 66:95-103.
21. Melton LJ III 1996 History of the Rochester Epidemiologic Project. Mayo Clin Proc 71:266-274.
22. Khosla S, Melton LJ III, Atkinson EJ, O'Fallon WM, Klee GG, Riggs BL 1998 Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen. J Clin Endocrinol Metab 83:2266-2274.
23. Gori F, Hofbauer LC, Conover CA, Khosla S 1999 Effects of androgens on the insulin-like growth factor system in an androgen-responsive human osteoblastic cell line. Endocrinology 140:5579-5586.
24. Campagnoli C, Biglia N, Cantamessa C, Lesca L, Lotano MR, Sismondi P 1998 Insulin-like growth factor I (IGF-I) serum level modifications during transdermal estradiol treatment in postmenopausal women: A possible bimodal effect depending on basal IGF-I values. Gynecol Endocrinol 12:259-266.
25. Ashton WS, Degnan BM, Daniel A, Francis GL 1995 Testosterone increases insulin-like growth factor-1 and insulin-like growth factor-binding protein. Ann Clin Lab Sci 25:381-388.
26. Kassem M, Okazaki R, Harris SA, Spelsberg TC, Conover CA, Riggs BL 1998 Estrogen effects on insulin-like growth factor gene expression in a human osteoblastic cell line with high levels of estrogen receptor. Calcif Tissue Int 62:60-66.
27. Munzer T, Rosen CJ, Harman SM, Pabst KM, St Clair C, Sorkin JD, Blackman MR 2006 Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men. Am J Physiol Endocrinol Metab 290:E1006- E1013.
28. Duda RJ Jr, O'Brien JF, Katzmann JA, Peterson JM, Mann KG, Riggs BL 1988 Concurrent assays of circulating bone Gla-protein and bone alkaline phosphatase: Effects of sex, age, and metabolic bone disease. J Clin Endocrinol Metab 66:951-957.
29. Delmas PD, Stenner D, Wahner HW, Mann KG, Riggs BL 1983 Increase in serum bone gamma-carboxyglutamic acid protein with aging in women. Implications for the mechanism of age-related bone loss. J Clin Invest 71:1316-1321.
30. Daughaday WH, Mariz IK, Blethen SL 1980 Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: A comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum. J Clin Endocrinol Metab 51:781-788.
31. O'Connor S, Baker HW, Dulmanis A, Hudson B 1973 The measurement of sex steroid binding globulin by differential ammonium sulphate precipitation. J Steroid Biochem 4:331-339.
32. Tremblay RR, Dube JY 1974 Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives. Contraception 10:599-605.
33. Conover CA, Rosen C 2002 The role of insulin-like growth factors and binding proteins in bone cell biology. In: Bilezikian JP, Raisz LG, Rodan GA (eds.) Principles of Bone Biology, 2nd ed., vol. 1. Academia Press, San Diego, CA, USA, pp. 801-815.
34. Grinspoon S, Miller K, Herzog D, Clemmons D, Klibanski A 2003 Effects of recombinant human insulin-like growth factor (IGF)-I and estrogen administration on IGF-I, IGF binding protein (IGFBP)-2, and IGFBP-3 in anorexia nervosa: A randomized-controlled study. J Clin Endocrinol Metab 88:1142-1149.
35. Eckstein F, Pavicic T, Nedbal S, Schmidt C, Wehr U, Rambeck W, Wolf E, Hoeflich A 2002 Insulin-like growth factor-binding protein-2 (IGFBP-2) overexpression negatively regulates bone size and mass, but not density, in the absence and presence of growth hormone/IGF-I excess in transgenic mice. Anat Embryol (Berl) 206:139-148.
36. Fagiolo U, Cossarizza A, Scala E, Fanales-Belasio E, Ortolani C, Cozzi E, Monti D, Franceschi C, Paganelli R 1993 Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol 23:2375-2378.
37. D'Amelio P, Grimaldi A, Pescarmona GP, Tamone C, Roato I, Isaia G 2005 Spontaneous osteoclast formation from peripheral blood mononuclear cells in postmenopausal osteoporosis. FASEB J 19:410-412.
38. Clowes JA, Riggs BL, Khosla S 2005 The role of the immune system in the pathophysiology of osteoporosis. Immunol Rev 208:207-227.
39. Weitzmann MN, Pacifici R 2005 The role of T lymphocytes in bone metabolism. Immunol Rev 208:154-168.
40. Palermo C, Manduca P, Gazzerro E, Foppiani L, Segat D, Barreca A 2004 Potentiating role of IGFBP-2 on IGF-II-stimulated alkaline phosphatase activity in differentiating osteoblasts. Am J Physiol Endocrinol Metab 286:E648-E657.
41. Conover CA, Johnstone EW, Turner RT, Evans GL, John Ballard FJ, Doran PM, Khosla S 2002 Subcutaneous administration of insulin-like growth factor (IGF)-II/IGF binding protein-2 complex stimulates bone formation and prevents loss of bone mineral density in a rat model of disuse osteoporosis. Growth Horm IGF Res 12:178-183.
42. Khosla S, Hassoun AA, Baker BK, Liu F, Zein NN, Whyte MP, Reasner CA, Nippoldt TB, Tiegs RD, Hintz RL, Conover CA 1998 Insulin-like growth factor system abnormalities in hepatitis C-associated osteosclerosis. Potential insights into increasing bone mass in adults. J Clin Invest 101:2165- 2173.
43. Mohan S, Farley JR, Baylink DJ 1995 Age-related changes in IGFBP-4 and IGFBP-5 levels in human serum and bone: Implications for bone loss with aging. Prog Growth Factor Res 6:465-473.